The FDA-led MAQC-IV/SEQC2 Consortium has published the data descriptor paper, i.e., Zhao Y. et al. Sci Data (2021), detailing the multi-center multi-platform whole-genome and whole-exome sequencing data sets for the breast cancer cell line HCC1395 and and its B lymphocyte-derived matched normal HCC1395BL. The genomic DNA was produced in a single batch by ATCC to ensure sample homogeneity. The following are some of the Consortium's papers that used those data sets:


Find all of SEQC2's publications: